查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813967

心血管設備市場規模、佔有率和趨勢分析報告：2025-2033 年產品、地區和細分市場預測

Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter, Mobile Cardiac Telemetry), Surgical Devices (Pacemakers, Stents)), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 240 Pages | 商品交期: 2-10個工作天內

價格

心血管設備市場摘要

預計 2024 年全球心血管設備市場價值將達到 537 億美元，到 2033 年將達到 1,067 億美元，2025 年至 2033 年的複合年成長率為 7.8%。

心血管疾病是全球最常見的疾病之一。

2024年1月，美國心臟協會 (AHA) 報告稱，心血管疾病 (CVD) 是美國死亡的主要原因，奪走了931,578人的生命，超過了所有癌症和慢性呼吸系統疾病造成的死亡人數總合。因此，心血管設備對於準確檢測和緩解心臟病至關重要，從而刺激了市場擴張。該市場的主要驅動力包括技術的快速發展、經濟實惠且有效設備的增多，以及對微創手術日益成長的需求。

慢性心血管疾病病例的迅速增加促進了市場擴張。心血管疾病的增多推動了對心血管設備的需求成長。心臟支架和冠狀動脈支架是最重要的心血管設備之一。它們有助於治療被認為對生命有嚴重威脅的心臟疾病，例如心臟病發作、冠狀動脈疾病、心房顫動和動脈擴張。 2024 年 5 月，世界衛生組織報告稱，心血管疾病 (CVD) 是歐洲殘疾和過早死亡的主要原因，佔每年死亡人數的 42.5% 以上，即每天約 10,000 人。男性死於心血管疾病的可能性約為女性的 2.5 倍，東亞和中亞年輕人（30-69 歲）死於心血管疾病的可能性幾乎是西歐年輕人的五倍。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章：心血管設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 滲透和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 心血管設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 管道分析

第4章：心血管設備：產品估算與趨勢分析

  • 心血管設備市場：產品亮點
  • 心血管設備市場：2024 年和 2033 年產品趨勢和市場佔有率分析
  • 診斷和監測設備
    • 2021-2033年診斷和監測設備估計和預測
  • 手術設備
    • 2021-2033年手術器械市場估計與預測

第5章心血管設備市場：按國家和產品分類的區域估計和趨勢分析

  • 區域儀表板
  • 市場規模、預測趨勢分析，2021-2033年：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • 2024年主要公司市佔率分析
  • 市場參與企業分類
    • Abbott
    • GE HealthCare
    • Edwards Lifesciences Corporation
    • WL Gore & Associates, Inc.
    • Siemens Healthcare GmbH
    • BIOTRONIK SE & Co. KG
    • Canon Medical Systems Asia Pte. Ltd.
    • B. Braun SE
    • LivaNova PLC
    • Cardinal Health
    • Medtronic
    • Boston Scientific Corporation
Product Code: 978-1-68038-992-0

Cardiovascular Devices Market Summary

The global cardiovascular devices market size was estimated at USD 53.7 billion in 2024 and is projected to reach USD 106.7 billion by 2033, growing at a CAGR of 7.8% from 2025 to 2033. Cardiovascular disease is one of the most prevalent medical conditions worldwide.

In January 2024, the American Heart Association (AHA) reported that cardiovascular disease (CVD) was the leading cause of death in the U.S., claiming 931,578 lives, surpassing deaths from all cancers and chronic respiratory diseases combined. Therefore, cardiovascular devices are crucial in accurately detecting and mitigating heart disorders, fueling market expansion. The main drivers of this market include rapid technical development, an increase in affordable and effective devices, and rising demand for minimally invasive procedures.

The surge in the number of cases of chronic cardiovascular disorders contributes to the market growth. Increasing cardiovascular disorders have led to an increased demand for cardiovascular devices. Heart or coronary artery stents are among the most essential cardiovascular devices. They facilitate the treatment of cardiac illnesses considered a serious risk to life, namely heart attacks, coronary disease, atrial fibrillation, and the expansion of clogged arteries. In May 2024, the WHO reported that cardiovascular diseases (CVDs) are the top cause of disability and premature death in Europe, accounting for over 42.5% of annual deaths, around 10,000 daily. Men are nearly 2.5 times more likely to die from CVDs than women, with young people (ages 30-69) in Eastern Europe and Central Asia facing a nearly fivefold higher risk compared to their Western European counterparts.

Global Cardiovascular Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiovascular devices market report based on product and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic & Monitoring Devices
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • MRI
  • Cardiovascular Ultrasound
    • 2D
    • 3D/4D
    • Doppler
  • Cardiac Diagnostic Catheters
  • PET Scanner
  • Surgical Devices
  • Cardiac Resynchronization Therapy (CRT)
    • CRT-Defibrillator
    • CRT-Pacemaker
  • Implantable Cardioverter Defibrillators (ICDs)
    • Single Chamber ICDs
    • Dual Chamber ICDs
  • Pacemakers
    • Conventional Pacemakers
    • Leadless Pacemakers
  • Coronary Stents
  • Catheters
  • Guidewires
  • Cannula
  • Valves
  • Occlusion Devices
  • Regional Outlook (Revenue in USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing prevalence of cardiovascular diseases
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Aging population
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Regulatory challenges
      • 3.3.2.2. High cost of development
  • 3.4. Cardiovascular Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Pipeline Analysis

Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis

  • 4.1. Cardiovascular Devices Market: Product Key Takeaways
  • 4.2. Cardiovascular Devices Market: Product Movement & Market Share Analysis, 2024 & 2033
  • 4.3. Diagnostic and Monitoring Devices
    • 4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.1. ECG
        • 4.3.1.1.1. ECG market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.2. Implantable Cardiac Monitors
        • 4.3.1.2.1. Implantable cardiac monitors market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.3. Holter Monitors
        • 4.3.1.3.1. Holter monitors market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.4. Mobile Cardiac Telemetry
        • 4.3.1.4.1. Mobile cardiac telemetry market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.5. MRI
        • 4.3.1.5.1. MRI estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.6. Cardiovascular Ultrasound
        • 4.3.1.6.1. Cardiovascular ultrasound market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.3.1.6.2. 2D
          • 4.3.1.6.2.1. 2D market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.3.1.6.3. 3D/4D
          • 4.3.1.6.3.1. 3D/4D market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.3.1.6.4. Doppler
          • 4.3.1.6.4.1. Doppler market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.7. Cardiac Diagnostic Catheters
        • 4.3.1.7.1. Cardiac diagnostic catheters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.8. PET Scanner
        • 4.3.1.8.1. PET scanner market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.4. Surgical Devices
    • 4.4.1. Surgical devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.1. Cardiac Resynchronization Therapy (CRT)
        • 4.4.1.1.1. Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.4.1.1.2. CRT-Defibrillator
          • 4.4.1.1.2.1. CRT-defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.4.1.1.3. CRT-Pacemaker
          • 4.4.1.1.3.1. CRT-pacemaker market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.2. Implantable Cardioverter Defibrillators (ICDs)
        • 4.4.1.2.1. Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.4.1.2.2. Single Chamber ICDs
          • 4.4.1.2.2.1. Single chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.4.1.2.3. Dual Chamber ICDs
          • 4.4.1.2.3.1. Dual chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.3. Pacemakers
        • 4.4.1.3.1. Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.4.1.3.2. Conventional Pacemakers
          • 4.4.1.3.2.1. Conventional pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.4.1.3.3. Leadless Pacemakers
          • 4.4.1.3.3.1. Leadless pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.4. Coronary Stents
        • 4.4.1.4.1. Coronary stents market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.5. Catheters
        • 4.4.1.5.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.6. Guidewires
        • 4.4.1.6.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.7. Cannula
        • 4.4.1.7.1. Cannula market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.8. Valves
        • 4.4.1.8.1. Valves market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.9. Occlusion devices
        • 4.4.1.9.1. Occlusion devices market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country and Product

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2024
  • 6.3. Market Participant Categorization
    • 6.3.1. Abbott
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Product benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. GE HealthCare
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Product benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Edwards Lifesciences Corporation
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Product benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. W. L. Gore & Associates, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Siemens Healthcare GmbH
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. BIOTRONIK SE & Co. KG
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Canon Medical Systems Asia Pte. Ltd.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. B. Braun SE
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. LivaNova PLC
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Cardinal Health
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Medtronic
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Boston Scientific Corporation
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 3 North America cardiovascular devices market, by region, 2021 - 2033 (USD Million)
  • Table 4 U.S. cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 5 Canada cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 6 Mexico cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 7 Europe cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 8 Europe cardiovascular devices market, by region, 2021 - 2033 (USD Million)
  • Table 9 Germany cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 10 UK cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 11 France cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 12 Italy cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 13 Spain cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 14 Sweden cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 15 Norway cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 16 Denmark cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 17 Asia Pacific cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 18 Asia Pacific cardiovascular devices market, by region, 2021 - 2033 (USD Million)
  • Table 19 China cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 20 Japan cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 21 India cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 22 Australia cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 23 Thailand cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 24 South Korea cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 25 Latin America cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 26 Latin America cardiovascular devices market, by region, 2021 - 2033 (USD Million)
  • Table 27 Brazil cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 28 Argentina cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 29 Middle East and Africa cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 30 Middle East and Africa cardiovascular devices market, by region, 2021 - 2033 (USD Million)
  • Table 31 South Africa cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 32 Saudi Arabia cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 33 UAE cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 34 Kuwait cardiovascular devices market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cardiovascular devices market: Market outlook
  • Fig. 9 Cardiovascular devices market: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cardiovascular devices market driver impact
  • Fig. 15 Cardiovascular devices market restraint impact
  • Fig. 16 Cardiovascular devices market strategic initiatives analysis
  • Fig. 17 Cardiovascular devices market: Product movement analysis
  • Fig. 18 Cardiovascular devices market: Product outlook and key takeaways
  • Fig. 19 Diagnostic and monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 ECG market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Implantable cardiac monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Holter monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Mobile cardiac telemetry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Cardiovascular ultrasound market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 2D market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 3D/4D market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Doppler market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Cardiac diagnostic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Pet scan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cardiac CT market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Doppler fetal monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 PET scanner market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Surgical devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 CRT-defibrillator market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 CRT-pacemaker market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Single Chamber ICDs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Dual Chamber ICDs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Pacemakers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Conventional pacemakers market estimates and forecasts, 2021 - 2033 (USD Million
  • Fig. 44 Leadless pacemaker market estimates and forecasts, 2021 - 2033 (USD Million
  • Fig. 45 Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Valves market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Occlusion devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Global cardiovascular devices market: Regional movement analysis
  • Fig. 51 Global cardiovascular devices market: Regional outlook and key takeaways
  • Fig. 52 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Market share of key market players cardiovascular devices market